COMPASS THERAPEUTICS, INC. Other Non-Current Assets
COMPASS THERAPEUTICS, INC. (CMPX) had Other Non-Current Assets of $568.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2025-02-27
- 2024-12-31: Other Assets, Noncurrent $568.00K.
- 2024-09-30: Other Assets, Noncurrent $568.00K.
- 2024-06-30: Other Assets, Noncurrent $320.00K.
- 2024-03-31: Other Assets, Noncurrent $320.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2024-12-31 | $568.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $568.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $320.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $320.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $320.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $320.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $320.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $320.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $320.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $320.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $320.00K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $320.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $320.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $320.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $320.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $320.00K 10-Q · filed 2021-04-30 |
| 2020-12-31 | $320.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | $177.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $69.00K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $129.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |